[二正丙基乙酸酯治疗难治性失神癫痫患者的临床试验]
[Clinical trial od Di-n-propylacetate in epileptics with therapy-resistant absences].
作者信息
Lüdemann G
出版信息
Psychiatr Neurol Med Psychol (Leipz). 1975 Feb;27(2):101-7.
PMID:812129
Abstract
The clinical trials of Di-n-propylacetate (Depakine, Labaz) produced favorable results with 15 patients, whose epilepsies were characterized by exceptional therapy-resistant absences, partly in combination with grand mal (4 patients). After discontinuation of DPA and renewed application of this drug at a later stage the patients made a good recovery.
摘要
二丙基乙酸（德巴金，拉巴兹公司生产）的临床试验对15名患者产生了良好效果，这些患者的癫痫以特别难以治疗的失神发作为特征，部分患者还伴有大发作（4名患者）。停用二丙基乙酸后，在后期重新使用该药，患者恢复良好。
Zotero 插件